A 52-year-old woman with hepatitis C cirrhosis undergoes surveillance imaging and is found to have a 4 cm HCC in the right lobe with no vascular invasion or extrahepatic metastases. Regarding the molecular pathogenesis and risk factors for HCC, all of the following are associated with HCC development EXCEPT:

Question

Accepted Answer

C. Hemochromatosis gene (HFE) mutations, which directly encode oncogenic proteins that promote malignant transformation of hepatocytes. ## Molecular Pathogenesis of HCC — The HFE Misconception

**Key Point:** While hereditary hemochromatosis (HFE mutations) is a risk factor for HCC, the mechanism is NOT direct oncogenic protein function. Instead, iron overload causes oxidative stress, inflammation, and cirrhosis — the cirrhosis, not the HFE protein itself, drives HCC risk.

### Correct Pathogenic Mechanisms in HCC

**High-Yield:** The three major pathways to HCC are:

1. **TP53 inactivation** (20–50% of cases)
   - Loss of p53 function → impaired apoptosis and cell cycle control
   - Associated with more aggressive phenotype and worse prognosis
   - Often occurs late in multistep hepatocarcinogenesis

2. **Hepatitis B (HBV) integration**
   - Viral DNA integrates into host genome → chromosomal instability
   - HBx protein activates Wnt/β-catenin and TGF-β pathways
   - Chronic inflammation and necrosis → cirrhosis → HCC

3. **Aflatoxin B1 (AFB1) exposure**
   - Metabolized to AFB1-8,9-epoxide → DNA adducts
   - Causes characteristic R249S TP53 mutation (G→T at codon 249)
   - Synergizes with HBV in endemic regions (Asia, Africa)

### Why HFE Mutations Are NOT Direct Oncogenic Drivers

**Clinical Pearl:** HFE mutations cause iron overload → oxidative stress → hepatocyte necrosis → cirrhosis → HCC. The HFE protein itself does not encode an oncogenic product; the risk is mediated by the *consequence* of iron accumulation, not the mutant protein's function.

| Risk Factor | Mechanism | Direct Oncogenic? |
|-------------|-----------|------------------|
| **TP53 inactivation** | Loss of tumor suppressor | YES — directly impairs apoptosis |
| **HBV integration** | Viral oncoproteins (HBx) | YES — HBx activates growth pathways |
| **AFB1 exposure** | Mutagenic DNA adducts | YES — causes TP53 mutations |
| **HFE mutations** | Iron overload → ROS → cirrhosis | NO — indirect via inflammation/fibrosis |

**Mnemonic:** **CHAP** — Cirrhosis, HBV, Aflatoxin, and (Paradoxically) iron overload causes HCC, but only HFE works *indirectly* through cirrhosis.

[cite:Robbins 10e Ch 20]

Answer

A. Chronic hepatitis B infection, which increases HCC risk through both integration of viral DNA into the host genome and HBx-mediated oncogenic signaling

Answer

B. Aflatoxin B1 exposure, which causes a characteristic G→T transversion mutation at codon 249 of TP53 (R249S mutation) in endemic regions

Answer

D. Inactivation of the TP53 tumor suppressor gene, which is mutated in approximately 20–50% of HCC cases and associated with worse prognosis

Explanation

Practice similar questions